Oxford Biomedica PLC — Director's Dealing 2014

Jun 19, 2014

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9818J

Oxford Biomedica PLC

19 June 2014

For filings with the FCA include the annex
For filings with issuer exclude the annex
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii				OXFORD BIOMEDICA PLC
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights					Yes
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached					No
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments					No
An event changing the breakdown of voting rights					No
Other (please specify):					No
3. Full name of person(s) subject to the notification obligation: iii		JOY GROUP LIMITED, a limited company registered in the British Virgin Islands.
4. Full name of shareholder(s) (if different from 3.):iv		See section 9.
5. Date of the transaction and date on which the threshold is crossed or reached: v		17 June 2014
6. Date on which issuer notified:		18 June 2014
7. Threshold(s) that is/are crossed or reached: vi, vii		10%

8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of shares if possible using the ISIN CODE	Situation previous to the triggering transaction					Resulting situation after the triggering transaction
Number of Shares			Number of Voting Rights		Number of shares		Number of voting rights			% of  voting rights x
Direct		Direct xi		Indirect xii	Direct			Indirect
GB0006648157	0			0		250,0000,000		250,0000,000			10.0217%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument			Expiration date xiii		Exercise/ Conversion Period xiv				Number of voting rights that may be acquired if the instrument is exercised/ converted.				% of voting rights
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial instrument		Exercise price		Expiration date xvii		Exercise/ Conversion period xviii		Number of voting rights instrument refers to				% of voting rights xix, xx
												Nominal			Delta
Total (A+B+C)
Number of voting rights							Percentage of voting rights
250,000,000							10.0217%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi
Joy Group Limited is a controlled undertaking of Al Joy 1 Settlement, which is a trust registered in Jersey.
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:
14. Contact name:	Tim Watts, Oxford BioMedica PLC
15. Contact telephone number:	01865 783000

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLBRGDLLGBBGSI